Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Variants in the PPARgamma gene affect fatty acid and glycerol metabolism in familial combined hyperlipidemia.

Molecular genetics and metabolism - 1 Nov 2003

Eurlings Petra M H, van der Kallen Carla J H, Vermeulen Vicky M M-J, de Bruin Tjerk W A

Abstract excerpt

Familial combined hyperlipidemia (FCHL) is a common genetic lipid disorder characterized by premature coronary artery disease, dyslipidemia, insulin resistance, and impaired adipose tissue free fatty acid (FFA) metabolism. Increased adipose tissue FFA flux towards the liver may, in part, contribu...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Case-Control Studies
Share to Fatty Acids
Share to Glycerol

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hyperlipidemia, Familial Combined

Share to Insulin Resistance

Share to Quantitative Trait Loci

Share to Receptors, Cytoplasmic and Nuclear

Share to Transcription Factors

Source

Identifiers

PMID: 14680975
DOI: 10.1016/S1096-7192(03)00138-0

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026. Prepared record publication-14680975-2026-09-01.1. Manifest publication-graph-cohort-2026-09-01.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Variants in the PPARgamma gene affect fatty acid and glycerol metabolism in familial combined hyperlipidemia.PMID 14680975Read ↗

Genetic variants in adipose triglyceride lipase influence lipid levels in familial combined hyperlipidemia.Semantic proximity Read ↗

Identification of the PPARA locus on chromosome 22q13.3 as a modifier gene in familial combined hyperlipidemia.Semantic proximity Read ↗

The Pro12A1a substitution in the peroxisome proliferator activated receptor gamma 2 is associated with an insulin-sensitive phenotype in families with familial combined hyperlipidemia and in nondiabetic elderly subjects with dyslipidemia.Semantic proximity Read ↗

High frequency of a retinoid X receptor gamma gene variant in familial combined hyperlipidemia that associates with atherogenic dyslipidemia.Semantic proximity Read ↗

Familial combined hyperlipidemia: An overview of the underlying molecular mechanisms and therapeutic strategiesSemantic proximity Read ↗

Novel PPARG mutation in multiple family members with chylomicronemia.Semantic proximity Read ↗

Familial partial lipodystrophy resulting from loss-of-function PPARγ pathogenic variants: phenotypic, clinical, and genetic features.Semantic proximity Read ↗

The genetics of familial combined hyperlipidaemia.Semantic proximity Read ↗

Molecular mechanisms, prevalence, and molecular methods for familial combined hyperlipidemia disease: A reviewSemantic proximity Read ↗

Genetics of familial combined hyperlipidemia.Semantic proximity Read ↗

Single gene contributions: genetic variants of peroxisome proliferator-activated receptor (isoforms alpha, beta/delta and gamma) and mechanisms of dyslipidemias.Semantic proximity Read ↗

Novel drugs in familial combined hyperlipidemia: lessons from type 2 diabetes mellitus.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.